ATE281178T1 - Protonenpumpenhemmer als kombinationstherapeutika mit antibakterielle wirkenden substanzen - Google Patents

Protonenpumpenhemmer als kombinationstherapeutika mit antibakterielle wirkenden substanzen

Info

Publication number
ATE281178T1
ATE281178T1 AT98942585T AT98942585T ATE281178T1 AT E281178 T1 ATE281178 T1 AT E281178T1 AT 98942585 T AT98942585 T AT 98942585T AT 98942585 T AT98942585 T AT 98942585T AT E281178 T1 ATE281178 T1 AT E281178T1
Authority
AT
Austria
Prior art keywords
proton pump
pump inhibitors
antibacterial substances
combination therapeutics
therapeutics
Prior art date
Application number
AT98942585T
Other languages
English (en)
Inventor
Klaus Tuch
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of ATE281178T1 publication Critical patent/ATE281178T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98942585T 1997-07-25 1998-07-21 Protonenpumpenhemmer als kombinationstherapeutika mit antibakterielle wirkenden substanzen ATE281178T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97112795 1997-07-25
PCT/EP1998/004553 WO1999004816A1 (en) 1997-07-25 1998-07-21 Proton pump inhibitor in therapeutic combination with antibacterial substances

Publications (1)

Publication Number Publication Date
ATE281178T1 true ATE281178T1 (de) 2004-11-15

Family

ID=8227119

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98942585T ATE281178T1 (de) 1997-07-25 1998-07-21 Protonenpumpenhemmer als kombinationstherapeutika mit antibakterielle wirkenden substanzen

Country Status (9)

Country Link
US (1) US6303644B1 (de)
EP (1) EP1003554B1 (de)
AT (1) ATE281178T1 (de)
AU (1) AU9067198A (de)
DE (1) DE69827392T2 (de)
ES (1) ES2232015T3 (de)
PT (1) PT1003554E (de)
SI (1) SI1003554T1 (de)
WO (1) WO1999004816A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020064555A1 (en) * 2000-09-29 2002-05-30 Dan Cullen Proton pump inhibitor formulation
MXPA04011018A (es) * 2002-05-07 2005-01-25 Altana Pharma Ag Nueva combinacion de inhibidores reversibles de la bomba de protones y productos terapueticos para tratar trastornos de las vias respiratorias.
NZ536918A (en) * 2002-05-07 2006-09-29 Altana Pharma Ag Combination of pantoprazole and a respiratory agent for the treatment of respiratory diseases
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US20060194748A1 (en) * 2005-02-28 2006-08-31 National University Corporation Nagoya University Methods for treating disorders induced by H. pylori infections and pharmaceutical compositions for the same
GB2479120A (en) 2010-03-26 2011-10-05 Cambridge Display Tech Ltd Organic electrolumunescent device having conductive layer connecting metal over well defining layer and cathode

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
ES2057338T3 (es) 1989-11-29 1994-10-16 Toa Eiyo Ltd Derivados de cicloheptenopiridina, procedimiento para su preparacion y agentes antiulcerosos que los contienen.
GB9018603D0 (en) * 1990-08-24 1990-10-10 Smith Kline French Lab Compositions
US5352688A (en) 1991-02-14 1994-10-04 The Mount Sinai School Of Medicine Of The City University Of New York Methods for the treatment of bradyphrenia in parkinson's disease
AU3247593A (en) 1991-12-20 1993-07-28 Warner-Lambert Company Therapeutic combinations useful in the treatment of gastroesophageal reflux disease
TW276996B (de) * 1992-04-24 1996-06-01 Astra Ab
US6132768A (en) 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
JPH09188624A (ja) * 1996-01-06 1997-07-22 Takeshi Azuma 肝性脳症治療剤又は肝性脳症予防剤
US6134344A (en) * 1997-06-26 2000-10-17 Lucent Technologies Inc. Method and apparatus for improving the efficiency of support vector machines

Also Published As

Publication number Publication date
EP1003554A1 (de) 2000-05-31
AU9067198A (en) 1999-02-16
ES2232015T3 (es) 2005-05-16
DE69827392T2 (de) 2005-10-27
WO1999004816A1 (en) 1999-02-04
EP1003554B1 (de) 2004-11-03
PT1003554E (pt) 2005-03-31
SI1003554T1 (en) 2005-04-30
DE69827392D1 (de) 2004-12-09
US6303644B1 (en) 2001-10-16

Similar Documents

Publication Publication Date Title
ATE461217T1 (de) Glp-1-verbindungen
ATE320457T1 (de) Polyurethanlösungen mit alkoxysilanstruktureinheiten
CR6577A (es) Inhibidores triciclicos de poli(adp-ribosa) polimerasas
BRPI0413449A (pt) compostos de quinoxalina
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
BR0007527A (pt) Fenilfenantridinas com atividade inibitória depde-iv
CY1107467T1 (el) Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων
ATE321048T1 (de) Beta-amino-tetrahydroimidazo(1,2-a)pyrazine und - tetrahydrotriazolo(4,3-a)pyrazine als dipeptidyl peptidase inhibitoren zur behandlung oder prevention von diabetes
TW200617013A (en) Diazabicyclic central nervous system active agents
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
DE60111570D1 (de) Isoindolin-1-on als glukokinaseaktivatoren
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
ATE233735T1 (de) Neue phenanthridine
TR200001203T2 (tr) Yeni birleşik maddeler
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
SE9904377D0 (sv) Pharmaceutical combinations
AU8330898A (en) Substituted heterocycles and their use in medicaments
ATE356810T1 (de) Polysubstituted 6-phenylphenanthridines mit pde- iv hemmender wirkung
PT1147103E (pt) Fenantridina-n-oxidos com actividade inibitoria de pde-iv
ATE516027T1 (de) Orazamid orotat zur vorbeugung von leberschäden
ATE405294T1 (de) Gezielt eingesetzte agenzien zur nervenregeneration
DE69827392D1 (de) Protonenpumpenhemmer als kombinationstherapeutika mit antibakterielle wirkenden substanzen
PT1147087E (pt) Feantridina-n-oxidos com actividade de inibicao de pde-iv
IS2254B (is) Meðhöndlun á risaeitlingasarkmeini með tálmum viðeitilfrumueiturslóðinni
DE50009838D1 (de) Humanes antibiotisches protein

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1003554

Country of ref document: EP

EEFA Change of the company name